Search

Postdoc Liz Cirulli started out in plant genetics but now co-leads Duke's Centenarian Project, which aims to find gene variants that account for longevity.

Training courses outline the challenges and opportunities in conducting cancer clinical trials.

Biomedical ontology is growing as an informatics specialty, and ontologies are proving to be powerful software and data-mining tools.

It's not always clear how or where to share clinical data in a way that protects patients' privacy.

Physician-scientist Rebecca Jackson's enthusiasm for research is matched only by her passion for Ohio State football.

Future physician-scientists should ask three questions when choosing a residency: What field? What type of residency? Which program?

Regulations seem to discourage academic scientists from partnering with industry, but such collaboration is essential to translational research.

A long-term commitment and a supportive environment allow the Yale Melanoma Research Group to excel.

Despite layoffs, pharmaceutical companies are hiring researchers to strengthen their early drug-development programs.

Recovery Act funding will give a boost to a field focused on containing health care costs while maintaining quality.

PECASE winner Benjamin tenOever is an unconventional virologist who's working to make his discoveries clinically relevant.

An encounter with a lupus patient crystallized one scientist's concept of "translational research" and fundamentally changed the focus of her lab.

Cultivating and nurturing your mentoring relationships are essential, particularly in the complex landscape of clinical and translational research.

Speed networking can be an effective way to promote new research collaborations.

Translational social scientists adapt research for the people it aims to serve and carry the lessons they learn in the community back to the lab.

Your choice of research problem may determine the course of your career, so choose carefully.

Empty training slots and ample job opportunities make the job outlook positive for physician-scientists.

"We're interested both in papers that identify a new feature of a disease or a new mechanism by which disease is regulated and studies that investigate the mechanism behind a response to an experimental drug or vaccine that's already in use." --Heather Van Epps